Accumulating recent clinical evidence suggests that FGF-23 plays a regulatory role in multiple pathological processes in cardiovascular diseases, such as coronary atherosclerosis, vascular calcification, left ventricular hypertrophy, and myocardial injury [7, 9, 10]. Here, FGF23 is linked to left ventricular hypertrophy.